197151-66-9Relevant academic research and scientific papers
Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids
Sodji, Quaovi H.,Kornacki, James R.,McDonald, John F.,Mrksich, Milan,Oyelere, Adegboyega K.
, p. 340 - 359 (2015)
Histone deacetylase (HDAC) inhibition has recently emerged as a novel therapeutic approach for the treatment of various pathological conditions including cancer. Currently, two HDAC inhibitors (HDACi) - Vorinostat and Romidepsin - have been approved for t
Folate-modified cholesterol-bearing pullulan as a drug carrier
-
Page/Page column 2, (2008/06/13)
Folate modified cholesterol-bearing pullulan (FA-CHP) was synthesized by the reaction of folic acid γ-2-aminoethylamide and 4-nitorophenyl chloroformate-activated cholesterol-bearing pullulan, wherein folate and pullulan are connected through a NH—CH
